Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease

Clinical trial NCT00483184 · COMPLETED

Trial details

NCT number: NCT00483184
Sponsor: Nobel Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Behcet Syndrome Behcet Disease Mucocutaneous Ulceration

Start date: 2006-04-01
Primary completion: 2008-04-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.